Ọgwụ na egbochikwa ọbara ogbugba nke ana-ere n'okpuru aha mba Treten na US na Novo nke iri na atọ na EU) bụ klas nke ọgwụ ọgwụ biopharmaceutical nke dabeere na XIII nkewa ndị ọzọ
Korte W (9 July 2014). "Catridecacog: a breakthrough in the treatment of congenital factor XIII A-subunit deficiency?". J Blood Med5: 107–13. DOI:10.2147/JBM.S35395. PMID 25031548.